Abstract

Recent developments in epidemiology have confirmed that airborne particulates are directly associated with respiratory pathology and mortality. Although clinical studies have yielded evidence of the effects of many types of fine particulates on human health, it still does not have a complete understanding of how physiological reactions are caused nor to the changes and damages associated with cellular and molecular mechanisms. Currently, most health assessment studies of particulate matter (PM) are conducted through cell culture or animal experiments. The results of such experiments often do not correlate with clinical findings or actual human reactions, and they also cause difficulty when investigating the causes of air pollution and associated human health hazards, the analysis of biomarkers, and the development of future pollution control strategies. Microfluidic-based cell culture technology has considerable potential to expand the capabilities of conventional cell culture by providing high-precision measurement, considerably increasing the potential for the parallelization of cellular assays, ensuring inexpensive automation, and improving the response of the overall cell culture in a more physiologically relevant context. This review paper focuses on integrating the important respiratory health problems caused by air pollution today, as well as the development and application of biomimetic organ-on-a-chip technology. This more precise experimental model is expected to accelerate studies elucidating the effect of PM on the human body and to reveal new opportunities for breakthroughs in disease research and drug development.

Highlights

  • With the development of epidemiology in recent years, scientists have confirmed that airborne particulate matter (PM) is directly associated with respiratory pathology and mortality (Kim et al, 2018; Khaniabadi et al, 2019)

  • In addition to the problem of increased risk of respiratory disease caused by compromised lung function, PM may increase the incidence of lung cancer (Raaschou-Nielsen et al, 2016)

  • PM is one of the most important components of air pollution that affects human health and disease. It is classified based on the relative size, which is defined in terms of aerodynamic equivalent diameter (AED), not directly by the diameter of their actual particles

Read more

Summary

INTRODUCTION

With the development of epidemiology in recent years, scientists have confirmed that airborne particulate matter (PM) is directly associated with respiratory pathology and mortality (Kim et al, 2018; Khaniabadi et al, 2019). The air quality statistics report of Beijing from 2013 to 2015 shows that the 2 year average PM2.5 concentrations from 69 to 89 μg/m3 and the daily average concentrations ranged from 3 to 437 μg/m3 (Batterman et al, 2016). These studies have shown that it is imperative to address the harmful effects of PM on the human body, in addition to traditionally known respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) (Hopke et al, 2019). It is essential to quickly and accurately elucidate the effects of PM on the human body, determine the causes of diseases, and formulate response strategies

PARTICULATE MATTER AND RESPIRATORY SYSTEM
PARTICULATE MATTER AND CARDIOVASCULAR EFFECTS
Deposits in upper nasal cavity and deep respiratory tract
Deposits inside alveolar tissue
ASSESSMENT FOR BIOLOGICAL TOXICITY OF FINE PARTICULATE MATTER
Findings
OPPORTUNITIES AND CHALLENGES
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call